Cingulate Inc. (CING) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cingulate Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.25
−5.06% today
Market cap
$80M
Overall quality
42/100
Kronos AI 30-day
−15.3%
0 of 8 simulated paths end higher
Cingulate Inc. (CING) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $80M. It trades at $5.25, down 5.06% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 3 analysts' average target of $20.33 implies +287.2% from today's price. Kronos AI's 30-day forecast is −15.3% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $20.33 |
| Low – high | $8.00 – $44.00 |
| Analysts | 3 |
| Upside to average | +287.2% |
Kronos AI 30-day forecast
| Expected close | $4.69 (−15.3%) |
| Likely range | −19.2% … −12.4% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 50 |
| Growth | 39 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.